Related Experiment Videos
Characterization of a tight-binding MMP-3 inhibitor using improved fluorescence spectroscopy techniques
M Finch-Arietta1, W Johnson, L Lusch
1Department of Arthritis Research, Hoffmann-La Roche, Inc., Nutley, NJ 07110.
Agents and Actions
|January 1, 1993
Summary
This study presents an improved assay for characterizing stromelysin (MMP-3) inhibitors. The new method accurately determines enzyme kinetics and inhibitor potency, crucial for developing new drugs.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Accurate kinetic characterization of stromelysin (MMP-3) inhibitors is vital for drug design.
- Previous assays had limitations in precise kinetic analysis.
Purpose of the Study:
- To develop and validate an improved assay for MMP-3 inhibitor kinetic characterization.
- To determine kinetic parameters (Km, Kcat/Km) for human MMP-3.
- To characterize a specific MMP-3 inhibitor (Ro 31-4724).
Main Methods:
- Modification of a previously described internally quenched peptide substrate assay.
- Use of purified human MMP-3 with 5% methanol or 5% DMSO.
- Mimicking fluorescence intensities using product peptide standards.
- Determination of kinetic parameters and inhibitor dissociation constant (Ki).
Main Results:
- Established a reliable assay for MMP-3 kinetic characterization.
- Determined Km = 39.2 microM and Kcat/Km = 4.6 microM/h for MMP-3 in 5% MeOH.
- Characterized Ro 31-4724 as a reversible, tight-binding inhibitor with a Ki of 26 nm.
Conclusions:
- The improved assay provides accurate kinetic characterization of MMP-3 inhibitors.
- This method is valuable for the rational design of potent MMP-3 inhibitors.
- Ro 31-4724 demonstrates significant inhibitory potential against MMP-3.